SCHEMBL3337332

SCHEMBL3337332

Cc1cc2nc(-c3ccccc3)[nH]c2cc1C

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 1/20 0.62
METAP1 P53582 1/20 0.62
CBFB Q13951 1/20 0.62
HPSE Q9Y251 1/20 0.60
NPC1 O15118 3/20 0.59
RAB9A P51151 3/20 0.59
GAA P10253 2/20 0.59
ADORA3 P0DMS8 1/20 0.59
KDM4E B2RXH2 3/20 0.58
ALDH1A1 P00352 3/20 0.58
HPGD P15428 3/20 0.58
MAPT P10636 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
TP53 P04637 2/20 0.58
HSD17B10 Q99714 2/20 0.58
GLA P06280 1/20 0.58
HTT P42858 1/20 0.58
GFER P55789 1/20 0.58
RCE1 Q9Y256 1/20 0.58
MEN1 O00255 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24075313 0.97 HPSE (0.61) METAP2METAP1CBFBHPSENPC1
SCHEMBL25722414 0.86 HPSE (0.64) METAP2METAP1CBFBHPSENPC1
SCHEMBL3132123 0.85 NPC1 (0.68) NPC1RAB9AGAAKDM4EALDH1A1
SCHEMBL24075259 0.84 GUSB (0.76) METAP2METAP1CBFBHPSENPC1
SCHEMBL4494716 0.84 NPC1 (0.68) METAP2METAP1CBFBNPC1RAB9A
SCHEMBL24075251 0.83 METAP2 (0.56) METAP2METAP1CBFBHPSENPC1
SCHEMBL21011385 0.83 NPC1 (0.70) NPC1RAB9AGAAKDM4EALDH1A1
SCHEMBL903717 0.83 NPC1 (0.66) NPC1RAB9AGAAKDM4EALDH1A1
SCHEMBL7393557 0.83 GUSB (0.79) HPSEGAAGUSB
SCHEMBL3333916 0.83 GUSB (0.79) HPSENPC1RAB9AGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0251760-B1 Rubber composition BRIDGESTONE CORP (JP) 1994-01-26 EP claimed
US-5140055-A Improved high speed grip performance BRIDGESTONE CORPORATION (JP) 1992-08-18 US claimed
CN-114989094-B Method for synthesizing benzimidazole derivative by visible light catalysis 云南民族大学 2023-09-29 CN disclosed
CN-114989094-A Method for synthesizing benzimidazole derivative by visible light catalysis 云南民族大学 2022-09-02 CN disclosed
CN-108043442-B Carbon-supported ruthenium nano material, preparation method thereof and application of carbon-supported ruthenium nano material in catalyzing reaction of alcohol and aromatic diamine 苏州大学 2021-03-19 CN disclosed
US-9169282-B2 Metal complexes MERCK PATENT GMBH (DE) 2015-10-27 US disclosed
US-9169282-B2 Metal complexes MERCK PATENT GMBH (DE) 2015-10-27 US disclosed
US-8198307-B2 Imidazole derivatives having aryl piperidine substituent, method for preparation thereof and pharmaceutical compositions containing same KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2012-06-12 US disclosed
US-20110284799-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2011-11-24 US disclosed
US-20110284799-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2011-11-24 US disclosed
US-20110269071-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, CHEMICAL AMPLIFICATION RESIST COMPOSITION, AND RESIST FILM AND PATTERN FORMING METHOD USING THE COMPOSITION FUJIFILM CORPORATION (JP) 2011-11-03 US disclosed
WO-2010086089-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2010-08-05 WO disclosed
US-20100145054-A1 IMIDAZOLE DERIVATIVES HAVING ARYL PIPERIDINE SUBSTITUENT, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-06-10 US disclosed
EP-0251760-B1 Rubber composition BRIDGESTONE CORP (JP) 1994-01-26 EP disclosed
US-5140055-A Improved high speed grip performance BRIDGESTONE CORPORATION (JP) 1992-08-18 US disclosed
EP-0251760-A2 Rubber composition Bridgestone Corporation (JP) 1988-01-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110284799-A1 METAL COMPLEXES SOD1, AP1M1, AP3M1 METAP2 1998/4885METAP1 2748/4885CBFB 790/4885
US-20100145054-A1 IMIDAZOLE DERIVATIVES HAVING ARYL PIPERIDINE SUBSTITUENT, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME TYR, MCHR1, MCHR2 METAP2 899/4885METAP1 672/4885CBFB 2926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.